Clinical Trials for Ovarian Cancer

Find clinical trials for ovarian cancer. Discover research opportunities and treatment options in your area.

409 Active Trials Found

Showing 409 trials on this page

Page 1 of 21

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

NCT ID: NCT05735080

This clinical trial is studying a new oral medication called INX-315, which is being developed to treat advanced cancers, specifically hormone receptor-positive breast cancer and certain types of o...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Detroit, Michigan, United States +12 more

A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors

NCT ID: NCT06238479

This clinical trial is investigating a new drug called LY4101174 to see if it is safe and effective for people with advanced solid tumors that have come back or spread to other parts of the body. T...

Recruiting

Phase: PHASE1 Type: interventional Locations: New York, New York, United States, Boston, Massachusetts, United States +34 more

A Study of XMT-1660 in Participants With Solid Tumors

NCT ID: NCT05377996

This clinical trial is studying a new treatment called XMT-1660 for patients with certain types of solid tumors, including different forms of breast cancer, ovarian cancer, and others. The main goa...

Recruiting

Phase: PHASE1 Type: interventional Locations: Chicago, Illinois, United States, Boston, Massachusetts, United States +21 more

A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian Cancer

NCT ID: NCT06888921

This clinical trial is studying a new treatment called COM701 to see if it can help women with relapsed platinum-sensitive ovarian cancer. The main goal is to find out if COM701 can slow down the p...

Recruiting

Phase: PHASE1 Type: interventional Locations: Chicago, Illinois, United States, Germantown, Tennessee, United States +2 more

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

NCT ID: NCT06503146

This clinical trial is studying a new imaging method using a special substance called 18F-FAPI-74 to help detect certain types of cancer more effectively. The goal is to find out if this new tracer...

Recruiting

Phase: PHASE2 Type: interventional Locations: Bethesda, Maryland, United States

Study on the Dynamic Changes of Metabolic Biomarkers and Their Prognostic Relationship in Ovarian Cancer

NCT ID: NCT06019923

This clinical trial is studying ovarian cancer, specifically looking for new ways to monitor and predict how the disease progresses in women diagnosed with high-grade serous ovarian cancer. Ovarian...

Recruiting

Type: observational Locations: Hangzhou, Zhejiang, China

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

NCT ID: NCT06824467

This clinical trial is studying a new treatment called sacituzumab tirumotecan (MK-2870) for women with platinum-sensitive recurrent ovarian cancer. The trial aims to find out if this treatment is ...

Recruiting

Phase: PHASE3 Type: interventional Locations: Goyang Si, Kyonggi Do, Korea, Republic Of, Omaha, Nebraska, United States +28 more

A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers

NCT ID: NCT04260802

This clinical trial is investigating a new treatment called OC-001 for patients with advanced or spreading cancers, including types like triple-negative breast cancer, gastric cancer, and non-small...

Recruiting

Phase: PHASE1 Type: interventional Locations: Edmonton, Alberta, Canada, Toronto, Ontario, Canada +3 more

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

NCT ID: NCT06695845

This clinical trial is studying a new treatment called zanidatamab for patients with certain types of solid tumors that have high levels of a protein called HER2. These tumors include breast, gastr...

Recruiting

Phase: PHASE2 Type: interventional Locations: Detroit, Michigan, United States, Houston, Texas, United States +20 more

A Study of BL0175 Injection in Postmenopausal Female Adults With HR-positive, Locally Advanced or Metastatic Cancer

NCT ID: NCT06738966

This clinical trial is investigating a new drug called BL0175 for treating postmenopausal women with certain types of advanced cancer, specifically breast, ovarian, and endometrial cancers that are...

Recruiting

Phase: PHASE1 Type: interventional Locations: Changchun, Jilin, China, Sydney, New South Wales, Australia +1 more

Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer

NCT ID: NCT06253520

This clinical trial is exploring a new treatment for adults with advanced cancers that have spread, such as colorectal, breast, lung, gastrointestinal, ovarian, and genitourinary cancers. The goal ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Bethesda, Maryland, United States

A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

NCT ID: NCT06257264

This clinical trial is studying a new treatment called BG-68501 for patients with advanced-stage tumors, including certain types of breast cancer, lung cancer, ovarian cancer, and others. The main ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Saint Louis, Missouri, United States, Brisbane, Queensland, Australia +44 more

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types

NCT ID: NCT05000294

This clinical trial is testing a new treatment approach for certain types of cancer that are usually hard to treat with existing immunotherapies, which are therapies designed to help the immune sys...

Recruiting

Phase: PHASE1 Type: interventional Locations: Gainesville, Florida, United States

Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

NCT ID: NCT05489211

The TROPION-PanTumor03 clinical trial is exploring a new treatment called Datopotamab Deruxtecan (Dato-DXd) for patients with advanced solid tumors, including types of cancer like endometrial, gast...

Recruiting

Phase: PHASE2 Type: interventional Locations: Barcelona, , Spain, Los Angeles, California, United States +97 more

A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products

NCT ID: NCT06885424

This clinical trial is designed to follow up with patients who have previously received gene therapy products from A2 Biotherapeutics for various types of solid tumors, including cancers like color...

Enrolling by invitation

Type: observational Locations: Rochester, Minnesota, United States, New York, New York, United States

Proactive Hemodynamic Management During Cytoreductive Surgery Plus HIPEC

NCT ID: NCT07070973

This clinical trial is studying a new way to carefully manage blood pressure and heart function during a major surgery called cytoreductive surgery with HIPEC, which is used to treat ovarian cancer...

Not yet recruiting

Phase: NA Type: interventional

Niraparib Rechallenge After Surgery in Ovarian Cancer Patients With Oligometastatic Progression

NCT ID: NCT06180356

The ANALLISA study is a clinical trial exploring a treatment called niraparib for women with ovarian cancer who have a specific type of disease progression called oligometastatic progression. This ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Madrid, , Spain, Barcelona, , Spain +10 more

Inhibiting Beta-adrenergic and COX-2 Signaling During the Perioperative Period to Reduce Ovarian Cancer Progression

NCT ID: NCT06839144

This clinical trial is looking at how certain medications might help women with ovarian cancer during and after surgery. Specifically, it investigates whether using propranolol, a beta-blocker that...

Recruiting

Phase: PHASE2 Type: interventional Locations: Ramat Gan, , Israel, Tel Aviv, , Israel

UNTOLD Ovarian Cancer Unmet Needs Survey

NCT ID: NCT07070726

This study, called the UNTOLD Ovarian Cancer Unmet Needs Survey, aims to better understand the ongoing concerns and needs of women living with ovarian cancer. The researchers want to hear directly ...

Not yet recruiting

Type: observational

Comprehensive Yoga Therapy Based Lifestyle Prehabilitation Program for Women With Ovarian Cancer

NCT ID: NCT06545604

This clinical trial is looking to see how a special yoga therapy program can help women with ovarian cancer who are about to start chemotherapy and then have surgery. The researchers want to find o...

Recruiting

Phase: NA Type: interventional Locations: Houston, Texas, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions